Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01863901 · ClinicalTrials.gov registry record · NA
Study Evaluating Treatment of Upper Limb Spasticity Using the Cryo-Touch III Device
A NA study, sponsored by Pacira Pharmaceuticals.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT01863901 is a NA study that has completed, run by Pacira Pharmaceuticals. The registered enrollment target is 19 participants.
The verdict
NCT01863901, a NA study, has completed, sponsored by Pacira Pharmaceuticals.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
A proof of concept study to evaluate the feasibility of safe and effective treatment of upper limb spasticity using the Cryo-Touch III Device.
Interventions
- DEVICE Treatment with Cryo-Touch III device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2013-04 |
| Est. Completion | 2013-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01863901
The ClinicalTrials.gov registry entry for NCT01863901 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pacira Pharmaceuticals, which has 88 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Treatment with Cryo-Touch III device is the first listed.
NCT01863901 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01863901 about?
NCT01863901 is a clinical study titled "Study Evaluating Treatment of Upper Limb Spasticity Using the Cryo-Touch III Device". A proof of concept study to evaluate the feasibility of safe and effective treatment of upper limb spasticity using the Cryo-Touch III Device.
What is the current status of trial NCT01863901?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2013-04. Estimated completion is 2013-10.
What interventions are being tested in trial NCT01863901?
The interventions under investigation include: Treatment with Cryo-Touch III device (DEVICE).
Who is sponsoring clinical trial NCT01863901?
This trial is sponsored by Pacira Pharmaceuticals, which has 88 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.